Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men aged over 18 years old.
- People with a confirmed diagnosis of prostate adenocarcinoma (a specific type of prostate cancer) proven through tissue testing.
- People who have previously had their prostate removed through surgery (radical prostatectomy).
- People whose cancer has shown signs of returning, with the recurrence identified in the local or nearby lymph node area through a PSMA PET scan (a specialised imaging test).
- People who have five or fewer affected lymph nodes showing on the PSMA PET scan.
- People with a good general health and activity level, as measured by a standard medical scale called ECOG, rated at 0 or 1 (meaning fully active or able to carry out light activities).
Who may not be able to join:
- People who have cancer spread to lymph nodes near the main abdominal artery (para-aortic nodes) or to distant parts of the body.
- People with a long-term inflammatory condition affecting the pelvic area.
- People for whom radiation treatment would not be considered safe for medical reasons (confirm with trial site).
- People who have previously received radiation treatment to the pelvic area.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 416-946-4501
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Grade ≥2 Toxicity for GU
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.